Ensuring psychedelic treatments and research do not leave anyone behind.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2024 DOI: 10.1038/s41386-023-01710-4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Mental health equity Healthcare access Marginalized communities Clinical trials diversity |
| Citations | 6 |
| Key points | Argues that ensuring health equity and health justice in psychedelic care delivery and research requires strategies to reduce disparities and preempt future disparities among minoritized and marginalized populations. |
Abstract
Psychedelics are a promising approach to caring for persons living with severe mental illness. However, as with all clinical treatments and research in the US, health equity concerns must be considered and addressed. Ensuring health equity and health justice in psychedelic care delivery and research will require strategies to not only reduce disparities and preempt future disparities among minoritized and marginalized populations.